In vitro activities of antimicrobial combinations against clinical isolates of Neisseria gonorrhoeae

Journal of Infection and Chemotherapy

Volumn 19, Issue 6, 2013, Pages 1218-1220

  Furuya, Ryusaburo ^a   Koga, Yosuke ^a   Irie, Shinichiro ^a   Ikeda, Fumiaki ^b   Kanayama, Akiko ^b   Kobayashi, Intetsu ^b   Tanaka, Masatoshi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b TOHO UNIVERSITY   (Japan)

Author keywords

Azithromycin; Combination; Neisseria gonorrhoeae; Spectinomycin

Indexed keywords

AZITHROMYCIN; CEFODIZIME; CEFTRIAXONE; GENTAMICIN; SPECTINOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; DRUG ANTAGONISM; DRUG POTENTIATION; FRACTIONAL INHIBITORY CONCENTRATION INDEX; GONORRHEA; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; SEXUALLY TRANSMITTED DISEASE;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; DRUG SYNERGISM; GONORRHEA; HUMANS; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; SPECTINOMYCIN;

EID: 84890859155     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-013-0597-6     Document Type: Article

References (11)

1. Unemo M, Nicholas R. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea. Future Microbiol. 2012;7:1401-22.
2. Tanaka M, Nakayama H, Furuya K, Konomi I, Irie S, Kanayama A, et al. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype. Int J Antimicrob Agents. 2006;27:20-6.
3. Centers for Disease Control and Prevention (CDC). Update to CDC's sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. Morb Mortal Wkly Rep. 2012;61:590-4.
4. Furuya R, Nakayama H, Kanayama A, Saika T, Iyoda T, Tatewaki M, et al. In vitro synergistic effects of double combinations of beta-lactams and azithromycin against clinical isolates of Neisseria gonorrhoeae. J Infect Chemother. 2006;12:172-6.
5. Onodera S, Kiyota H, Endo K, Suzuki H, Hosobe T, Takahashi T, et al. Enhancement of antimicrobial activities of cefteram or clavulanic acid/amoxicillin against cefixime-resistant Neisseria gonorrhoeae in the presence of clarithromycin or azithromycin. J Infect Chemother. 2006;12:207-9.
6. Pereira R, Cole MJ, Ison CA. Combination therapy for gonorrhoea: in vitro synergy testing. J Antimicrob Chemother. 2013;68:640-3.
7. Japanese Society of Sexually Transmitted Infections. The guideline of the diagnosis and treatment for gonococcal infections. Jpn J STI 2011;22(suppl):52-59.
8. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: sixteenth informational supplement. Document M100-S22. Wayne: CLSI; 2012.
9. Moody J. Synergism testing: broth microdilution checkerboard and broth macrodilution methods. In: Garcia LS, Editor. Clinical microbiology procedures handbook. 2nd ed. Update. Washington, DC: ASM Press; 2007. p. 5.12.1-5.12.23.
10. Hutt DM, Judson FN. Epidemiology and treatment of oropharyngeal gonorrhea. Ann Intern Med. 1986;104:655-8.
11. Bignell C, Garley J. Azithromycin in the treatment of infection with Neisseria gonorrhoeae. Sex Transm Infect. 2010;86:422-6.